U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Levofloxacin Oral, Injection products
  1. Development Resources

Levofloxacin Oral, Injection products

 

Minimum Inhibitory
Concentrations
(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterobacterales

M100 standard is recognized

Salmonella spp.

M100 standard is recognized

-

-

-

Pseudomonas aeruginosa

M100 standard is recognized

Methicillin-susceptible
Staphylococcus aureus

≤2

4

≥8

≥17

14–16

≤13

Enterococcus spp.

M100 standard is recognized

Haemophilus influenzae and parainfluenzae

M100 standard is recognized

Streptococcus pneumoniae

M100 standard is recognized

Streptococcus spp β- Hemolytic Group

M100 standard is recognized

Bacillus anthracis

M45 standard is recognized

-

-

-

Yersinia pestis

M45 standard is recognized

-

-

-

S = Susceptible; I = Intermediate; R = Resistant

Exceptions to the recognized standard

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Acinetobacter spp.

Burkholderia cepacia complex

Stenotrophomonas maltophilia

Other Non-Enterobacterales

Streptococcus spp. Viridans Group

Neisseria meningitidis

Back to Top